Zenotech Laboratories Limited (BOM:532039)

Zenotech Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	304.24	267.02	196.86	111.42	24.15
Short-Term Investments	-	-	-	0.02	-	-
Cash & Short-Term Investments	304.24	304.24	267.02	196.88	111.42	24.15
Cash Growth	13.94%	13.94%	35.63%	76.69%	361.42%	-1.75%
Accounts Receivable	-	89.66	74.54	32.49	33.24	39.28
Other Receivables	-	11.41	11.22	15.33	6.76	1.58
Receivables	-	101.07	85.77	47.82	39.99	40.86
Inventory	-	0.73	0.91	8.6	0.24	1.35
Prepaid Expenses	-	1.81	2.04	1.39	2.98	3.84
Other Current Assets	-	2.54	2.19	6.94	8.01	3.56
Total Current Assets	-	410.39	357.94	261.63	162.65	73.75
Property, Plant & Equipment	-	658.93	644.41	675.38	703.64	711.88
Long-Term Deferred Tax Assets	-	-	39.4	65.26	93.58	122.75
Other Long-Term Assets	-	42.21	66.69	59.8	48.87	32.46
Total Assets	-	1,112	1,108	1,062	1,009	940.84

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	36.96	25.24	32.92	34.77	20.66
Accrued Expenses	-	75.65	81.36	97.15	126.19	129.98
Current Income Taxes Payable	-	-	12.15	-	-	-
Current Unearned Revenue	-	5.11	5.11	5.11	5.11	5.11
Other Current Liabilities	-	2.84	0.14	0.05	-	-
Total Current Liabilities	-	120.56	124	135.23	166.07	155.76
Long-Term Debt	-	-	-	-	-	60
Long-Term Unearned Revenue	-	0.19	0.94	9.7	9.73	3.21
Pension & Post-Retirement Benefits	-	12.15	7.09	6.16	5.26	4.52
Long-Term Deferred Tax Liabilities	-	8.31	-	-	-	-
Other Long-Term Liabilities	-	19.1	15.1	5.55	4.97	10.95
Total Liabilities	-	160.32	147.13	156.65	186.03	234.44

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	610.31	610.31	610.31	610.31	610.31
Additional Paid-In Capital	-	2,095	2,095	2,095	2,095	2,095
Retained Earnings	-	-1,755	-1,744	-1,800	-1,883	-1,999
Shareholders' Equity	951.21	951.21	961.31	905.42	822.7	706.4
Total Liabilities & Equity	-	1,112	1,108	1,062	1,009	940.84

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	-	-	-	-	60
Net Cash (Debt)	304.24	304.24	267.02	196.88	111.42	-35.85
Net Cash Growth	13.94%	13.94%	35.63%	76.69%	-	-
Net Cash Per Share	5.04	4.99	4.38	3.23	1.83	-0.59
Filing Date Shares Outstanding	65.07	61.03	61.03	61.03	61.03	61.03
Total Common Shares Outstanding	65.07	61.03	61.03	61.03	61.03	61.03
Working Capital	-	289.83	233.94	126.4	-3.42	-82.01
Book Value Per Share	15.70	15.59	15.75	14.84	13.48	11.57
Tangible Book Value	951.21	951.21	961.31	905.42	822.7	706.4
Tangible Book Value Per Share	15.70	15.59	15.75	14.84	13.48	11.57
Land	-	10.83	10.83	10.83	10.83	10.83
Buildings	-	224.47	212.53	211.96	211.96	211.96
Machinery	-	1,013	939.58	917.68	844.97	828.49
Construction In Progress	-	36.03	35.73	19.56	49.79	2.79

Data Source: S&P Global Market Intelligence Last updated: Jul 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error